CNSP
CNS Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $7.47M
- Employees
- 8
- Latest publication
- 2026-09-29
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 3,140USD | 3,140USD | 0USD | 0USD |
| Cost Of Revenue | 1,868USD | -2,898USD | 697USD | 1,101USD | 1,100USD | 985USD | 751USD | 752USD |
| Gross Profit | -1,868USD | 2,898USD | -697USD | -1,101USD | -1,100USD | -985USD | -751USD | -752USD |
| Research Development | 3,543,723USD | 3,165,162USD | 2,196,828USD | 1,167,045USD | 3,242,905USD | 1,498,176USD | 4,244,993USD | 1,116,562USD |
| Selling General Administrative | 1,431,482USD | 2,820,964USD | 1,056,560USD | 1,242,340USD | 1,094,755USD | 1,701,872USD | 1,383,913USD | 1,411,573USD |
| Total Operating Expenses | 4,973,337USD | 5,989,024USD | 3,252,691USD | 2,408,284USD | 4,336,560USD | 3,199,063USD | 5,628,155USD | 2,527,383USD |
| Operating Income | -4,975,205USD | -5,986,126USD | -3,253,388USD | -2,409,385USD | -4,337,660USD | -3,200,048USD | -5,628,906USD | -2,528,135USD |
| Interest Income | 44,270USD | 35,605USD | 37,023USD | 38,609USD | 42,548USD | 26,456USD | 25,230USD | 1,845USD |
| Interest Expense | 6,111USD | 2,721USD | 2,116USD | 4,185USD | 6,208USD | 2,774USD | 2,258USD | 4,463USD |
| Net Interest Income | 38,159USD | 32,884USD | 34,907USD | 34,424USD | 36,340USD | 23,682USD | 22,972USD | -2,618USD |
| Income Before Tax | -4,937,046USD | -5,955,802USD | -3,218,481USD | -2,374,961USD | -4,301,320USD | -3,176,366USD | -5,605,934USD | -2,530,753USD |
| Net Income | -4,937,046USD | -5,955,802USD | -3,218,481USD | -2,374,961USD | -4,301,320USD | -3,176,366USD | -5,605,934USD | -2,530,753USD |
| Net Income From Continuing Ops | -4,937,046USD | -5,955,802USD | -3,218,481USD | -2,374,961USD | -4,301,320USD | -3,176,366USD | -5,605,934USD | -2,530,753USD |
| Ebit | -4,975,205USD | -5,953,081USD | -3,216,365USD | -2,370,776USD | -4,295,112USD | -3,173,592USD | -5,603,676USD | -2,526,290USD |
| Ebitda | -4,973,337USD | -5,952,061USD | -3,215,668USD | -2,369,675USD | -4,294,012USD | -3,172,607USD | -5,602,925USD | -2,525,538USD |
| Depreciation And Amortization | 1,868USD | 1,020USD | 697USD | 1,101USD | 1,100USD | 985USD | 751USD | 752USD |
| Reconciled Depreciation | 1,868USD | 1,020USD | 697USD | 1,101USD | 1,100USD | 985USD | 751USD | 752USD |
| Total Other Income Expense Net | 38,159USD | 30,324USD | 34,907USD | 34,424USD | 36,340USD | 23,682USD | 22,972USD | -2,618USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 752USD |
| Income Tax Expense | — | — | — | — | — | — | — | -2USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 9,771,940USD | 9,290,143USD | 14,095,606USD | 9,300,055USD | 9,805,075USD | 5,061,734USD | 1,854,334USD | 21,267USD |
| Selling General Administrative | 6,214,619USD | 5,611,800USD | 4,769,502USD | 5,967,052USD | 4,680,840USD | 4,392,873USD | 1,978,643USD | 860,520USD |
| Total Operating Expenses | 15,986,559USD | 14,898,637USD | 18,860,974USD | 14,921,213USD | 14,472,845USD | 9,443,511USD | 3,832,977USD | 881,787USD |
| Operating Income | -15,986,559USD | -14,901,943USD | -18,865,108USD | -14,932,969USD | -14,485,915USD | -9,454,607USD | -3,832,977USD | -881,787USD |
| Interest Income | 153,785USD | 60,262USD | 27,687USD | 0USD | — | — | 44,230USD | 46,700USD |
| Interest Expense | 15,230USD | 16,119USD | 13,805USD | 7,027USD | 9,285USD | 3,264USD | 44,234USD | 46,697USD |
| Net Interest Income | 138,555USD | 44,142USD | 7,449USD | -7,027USD | -9,285USD | -3,264USD | -44,234USD | -46,697USD |
| Income Before Tax | -15,850,564USD | -14,857,801USD | -18,851,226USD | -15,274,134USD | -14,495,200USD | -9,457,871USD | -3,877,211USD | -7,391,899USD |
| Net Income | -15,850,564USD | -14,857,801USD | -18,851,226USD | -15,274,134USD | -14,495,200USD | -9,457,871USD | -3,919,490USD | -7,391,899USD |
| Net Income From Continuing Ops | -15,850,564USD | -14,857,801USD | -18,612,827USD | -15,274,134USD | -14,036,578USD | -9,457,871USD | -3,877,211USD | -7,391,899USD |
| Ebit | -15,835,334USD | -14,841,681USD | -18,865,108USD | -15,267,107USD | -14,485,915USD | -9,454,607USD | -3,832,977USD | -7,345,198USD |
| Ebitda | -15,831,416USD | -14,838,375USD | -18,860,974USD | -15,255,351USD | -14,472,845USD | -9,443,511USD | -3,831,022USD | -6,463,411USD |
| Depreciation And Amortization | 3,918USD | 3,306USD | 4,134USD | 11,756USD | 13,070USD | 11,096USD | 1,955USD | 881,787USD |
| Reconciled Depreciation | 3,918USD | 3,306USD | 5,562USD | 11,756USD | 13,070USD | 11,096USD | 1,955USD | — |
| Total Other Income Expense Net | 135,995USD | 44,142USD | 13,882USD | -341,165USD | -9,285USD | -3,264USD | -44,234USD | -6,510,112USD |
| Cost Of Revenue | — | 3,306USD | 4,134USD | 11,756USD | 13,070USD | 11,096USD | 1,955USD | — |
| Gross Profit | — | -3,306USD | -4,134USD | -11,756USD | -13,070USD | -11,096USD | -1,955USD | — |
| Selling And Marketing Expenses | — | — | 4,134USD | — | — | — | — | — |
| Income Tax Expense | — | — | -4USD | 7,027USD | 9,285USD | 3,264USD | 42,279USD | 46,697USD |
| Net Income Applicable To Common Shares | — | — | — | — | -14,036,578USD | -9,457,871USD | -3,877,211USD | -7,391,899USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 21,938,000USD | 4,653,192USD | 8,623,466USD | 11,869,258USD | 14,507,875USD | 13,749,315USD | 8,700,943USD | 7,409,273USD |
| Cash And Equivalents | 19,985,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 21,923,000USD | 4,051,091USD | 8,102,801USD | 11,391,735USD | 14,137,820USD | 13,722,026USD | 8,658,508USD | 7,388,098USD |
| Other Current Assets | 1,865,000USD | 1,100,214USD | 901,787USD | 1,527,648USD | 2,007,947USD | 674,434USD | 1,314,591USD | 414,974USD |
| Total Liabilities | 3,738,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,738,000USD | 4,582,487USD | 4,100,910USD | 1,959,117USD | 1,382,890USD | 2,779,193USD | 2,524,332USD | 4,056,929USD |
| Total Stockholder Equity | 18,200,000USD | 70,705USD | 4,522,556USD | 9,910,141USD | 13,124,985USD | 10,970,122USD | 6,176,611USD | 3,352,344USD |
| Total Equity Including Noncontrolling Interest | 18,200,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 15,000USD | 22,014USD | 17,703USD | 3,107USD | 3,804USD | 4,905USD | 6,005USD | 2,802USD |
| Accounts Payable | 3,738,000USD | 4,350,134USD | — | 1,928,324USD | 1,261,123USD | 2,568,520USD | 2,198,260USD | 4,025,742USD |
| Common Stock | 2,000USD | 811USD | 633USD | 574USD | 504USD | 2,945USD | 1,414USD | 33,446USD |
| Retained Earnings | -107,800,000USD | -105,212,314USD | -100,275,268USD | -94,319,466USD | -91,100,985USD | -88,726,024USD | -84,424,704USD | -81,248,338USD |
| Total Liab | — | 4,582,487USD | 4,100,910USD | 1,959,117USD | 1,382,890USD | 2,779,193USD | 2,524,332USD | 4,056,929USD |
| Capital Stock | — | 811USD | 633USD | 574USD | 504USD | 2,945USD | 1,414USD | 33,446USD |
| Cash | — | 2,950,877USD | 7,201,014USD | 9,864,087USD | 12,129,873USD | 13,047,592USD | 6,461,378USD | 6,973,124USD |
| Cash And Short Term Investments | — | 2,950,877USD | 7,201,014USD | 9,864,087USD | 12,129,873USD | 13,047,592USD | 6,461,378USD | 6,973,124USD |
| Net Debt | — | -2,718,524USD | -6,872,443USD | -9,833,294USD | -12,008,106USD | -12,836,919USD | -6,135,306USD | -6,941,937USD |
| Short Term Debt | — | 232,353USD | 328,571USD | 30,793USD | 121,767USD | 210,673USD | 326,072USD | 31,187USD |
| Short Long Term Debt | — | 232,353USD | 328,571USD | 30,793USD | 121,767USD | 210,673USD | 326,072USD | 31,187USD |
| Short Long Term Debt Total | — | 232,353USD | 328,571USD | 30,793USD | 121,767USD | 210,673USD | 326,072USD | 31,187USD |
| Common Stock Shares Outstanding | — | 676,172shares | 443,369shares | 558,868shares | 370,128shares | 227,219shares | 117,796shares | 36,968shares |
| Non Current Assets Total | — | 602,100USD | 520,665USD | 477,523USD | 370,055USD | 27,289USD | 42,435USD | 21,175USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 580,086USD | 502,962USD | 474,416USD | 366,251USD | 22,384USD | 36,430USD | 18,373USD |
| Net Working Capital | — | -504,148USD | 4,001,891USD | 9,432,618USD | 12,754,930USD | 10,942,833USD | 6,134,176USD | 3,331,169USD |
| Unclassified Equity | — | 105,281,397USD | 104,796,558USD | 104,228,459USD | 104,224,962USD | 99,690,256USD | 90,598,487USD | 84,533,790USD |
| Other Current Liab | — | — | 3,772,339USD | 1,928,324USD | — | 2,568,520USD | 2,198,260USD | 8,051,484USD |
| Net Receivables | — | — | 0USD | 0USD | 0USD | 882,539USD | 882,539USD | — |
| Unclassified Current Liabilities | — | — | — | -1,959,117USD | — | -2,779,193USD | -2,524,332USD | -8,082,671USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,623,466USD | 8,700,943USD | 1,700,853USD | 13,053,115USD | 8,757,385USD | 15,853,412USD | 7,912,075USD | 683,333USD |
| Other Current Assets | 901,787USD | 1,314,591USD | 1,042,449USD | 2,509,238USD | 2,472,933USD | 1,456,350USD | 652,622USD | 305,397USD |
| Total Liab | 4,100,910USD | 2,524,332USD | 6,132,968USD | 4,920,259USD | 2,135,566USD | 1,905,428USD | 311,000USD | 1,232,631USD |
| Total Stockholder Equity | 4,522,556USD | 6,176,611USD | -4,432,115USD | 8,132,856USD | 6,621,819USD | 13,947,984USD | 7,601,076USD | -549,298USD |
| Other Current Liab | 3,772,339USD | 2,198,260USD | 5,832,162USD | 828,391USD | 224,949USD | 519,804USD | 21,500USD | 763,249USD |
| Common Stock | 633USD | 1,414USD | 6,214USD | 1,617USD | 27,927USD | 23,856USD | 16,450USD | 12,695USD |
| Capital Stock | 633USD | 1,414USD | 6,214USD | 1,617USD | 27,927USD | 23,856USD | 16,450USD | 12,695USD |
| Retained Earnings | -100,275,268USD | -84,424,704USD | -69,566,903USD | -50,715,677USD | -34,982,921USD | -20,946,343USD | -11,488,472USD | -7,611,261USD |
| Cash | 7,201,014USD | 6,461,378USD | 548,721USD | 10,055,407USD | 5,004,517USD | 14,039,493USD | 7,241,288USD | 282,736USD |
| Cash And Short Term Investments | 7,201,014USD | 6,461,378USD | 548,721USD | 10,055,407USD | 5,004,517USD | 14,039,493USD | 7,241,288USD | 282,736USD |
| Total Current Assets | 8,102,801USD | 8,658,508USD | 1,591,170USD | 12,564,645USD | 7,477,450USD | 15,495,843USD | 7,893,910USD | 588,133USD |
| Total Current Liabilities | 4,100,910USD | 2,524,332USD | 6,132,968USD | 4,920,259USD | 2,135,566USD | 1,905,428USD | 311,000USD | 1,232,631USD |
| Net Debt | -6,872,443USD | -6,135,306USD | -247,915USD | -9,645,439USD | -4,616,723USD | -13,600,199USD | -7,241,288USD | 34,182USD |
| Short Term Debt | 328,571USD | 326,072USD | 300,806USD | 409,968USD | 387,794USD | 439,294USD | — | 316,918USD |
| Short Long Term Debt | 328,571USD | 326,072USD | 300,806USD | 409,968USD | 387,794USD | 439,294USD | — | 316,918USD |
| Short Long Term Debt Total | 328,571USD | 326,072USD | 300,806USD | 409,968USD | 387,794USD | 439,294USD | — | 316,918USD |
| Net Receivables | 0USD | 882,539USD | 0USD | — | — | — | — | — |
| Property Plant Equipment Net | 17,703USD | 6,005USD | 4,933USD | 5,664USD | 16,109USD | 23,431USD | 18,165USD | — |
| Common Stock Shares Outstanding | 443,369shares | 31,853shares | 126shares | 45shares | 29shares | 18shares | 18shares | 18shares |
| Non Current Assets Total | 520,665USD | 42,435USD | 109,683USD | 488,470USD | 1,279,935USD | 357,569USD | 18,165USD | 95,200USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 4,091,868USD | 1,910,617USD | 1,385,624USD | 289,499USD | 445,783USD |
| Non Currrent Assets Other | 502,962USD | 36,430USD | 104,750USD | 482,806USD | 1,263,826USD | 334,138USD | 0USD | 95,200USD |
| Net Working Capital | 4,001,891USD | 6,134,176USD | -4,541,798USD | 7,644,386USD | 5,341,884USD | 13,590,415USD | 7,582,911USD | -644,498USD |
| Unclassified Equity | 104,796,558USD | 90,598,487USD | 65,122,360USD | 58,845,299USD | 41,548,886USD | 34,846,615USD | 19,056,648USD | 7,036,573USD |
| Accounts Payable | — | 2,198,260USD | 5,832,162USD | 3,681,900USD | 1,522,823USD | 946,330USD | 289,499USD | 128,865USD |
| Unclassified Current Liabilities | — | -2,524,332USD | -6,132,968USD | — | — | — | — | — |
| Other Assets | — | — | 1USD | — | 1,263,826USD | 334,138USD | — | 95,200USD |
| Current Deferred Revenue | — | — | -5,832,162USD | — | — | — | — | 23,599USD |
| Unclassified Non Current Liabilities | — | — | — | 4,091,868USD | 1,576,479USD | 1,051,486USD | — | — |
| Deferred Long Term Liab | — | — | — | — | 334,138USD | 334,138USD | — | 95,200USD |
| Net Tangible Assets | — | — | — | — | 6,621,819USD | 13,613,846USD | 7,601,076USD | -549,298USD |
| Unclassified Non Current Assets | — | — | — | — | -1,263,826USD | — | — | — |
| Good Will | — | — | — | — | — | 334,138USD | — | — |
| Property Plant Equipment Gross | — | — | — | — | — | 23,431USD | 18,165USD | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,937,046USD | -5,955,802USD | -3,218,481USD | -2,374,961USD | -4,301,320USD | -3,176,366USD | -5,605,934USD | -2,530,753USD |
| Depreciation | 1,868USD | 1,020USD | 697USD | 1,101USD | 1,100USD | 985USD | 751USD | 752USD |
| Stock Based Compensation | 2,555USD | 85,068USD | 18,452USD | 21,841USD | 62,367USD | 129,900USD | 271,779USD | 234,345USD |
| Other Non Cash Items | 2,555USD | 3,817,293USD | 18,452USD | — | 1USD | 1USD | -672,193USD | 234,345USD |
| Change In Working Capital | 284,005USD | -999,349USD | 1,025,161USD | -2,991,241USD | 995,946USD | -2,425,379USD | -794,393USD | 645,263USD |
| Total Cash From Operating Activities | -4,648,618USD | -3,051,770USD | -2,174,170USD | -5,343,260USD | -3,241,907USD | -5,470,859USD | -6,799,990USD | -1,650,393USD |
| Capital Expenditures | -6,182USD | -18,175USD | 0USD | 0USD | -4,188USD | -4,188USD | -3USD | -3USD |
| Free Cash Flow | -4,654,800USD | -3,069,945USD | -2,174,170USD | -5,343,260USD | -3,241,907USD | -5,475,047USD | -6,799,990USD | -1,650,390USD |
| Total Cashflows From Investing Activities | -6,179USD | -18,175USD | — | — | -4,188USD | -4,188USD | — | — |
| Net Borrowings | -96,218USD | -30,791USD | -90,974USD | -88,906USD | -86,882USD | -31,187USD | -92,061USD | — |
| Total Cash From Financing Activities | 404,660USD | 406,872USD | -91,616USD | 4,425,541USD | 9,828,121USD | 4,963,301USD | 12,281,555USD | 2,326,726USD |
| Sale Purchase Of Stock | 0USD | -1,114USD | 557USD | 0USD | -557USD | — | 0USD | 0USD |
| Issuance Of Capital Stock | 500,878USD | 501,745USD | 0USD | 4,511,664USD | 9,033,021USD | 5,004,489USD | 12,413,616USD | 2,424,411USD |
| Change In Cash | -4,250,137USD | -2,663,073USD | -2,265,786USD | -917,719USD | 6,586,214USD | -511,746USD | 5,481,565USD | 676,333USD |
| Begin Period Cash Flow | 7,201,014USD | 9,864,087USD | 12,129,873USD | 13,047,592USD | 6,461,378USD | 6,973,124USD | 1,491,559USD | 815,226USD |
| End Period Cash Flow | 2,950,877USD | 7,201,014USD | 9,864,087USD | 12,129,873USD | 13,047,592USD | 6,461,378USD | 6,973,124USD | 1,491,559USD |
| Other Cashflows From Financing Activities | — | -64,082USD | -1,486USD | 2,783USD | 882,539USD | -10,000USD | -40,000USD | -7,829USD |
| Unclassified Financing Cash Flow | — | — | — | 4,511,664USD | 9,033,021USD | — | 12,413,616USD | 2,334,555USD |
| Investments | — | — | — | — | — | -4,188USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 3USD | -3USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,850,564USD | -14,857,801USD | -18,851,226USD | -15,274,134USD | -14,495,200USD | -9,457,871USD | -3,877,211USD | -7,391,899USD |
| Depreciation | 3,918USD | 3,306USD | 4,134USD | 11,756USD | 13,070USD | 11,096USD | 1,955USD | 1,955USD |
| Stock Based Compensation | 187,728USD | 838,957USD | 1,007,417USD | 1,202,966USD | 1,723,842USD | 1,293,392USD | 477,096USD | 110,240USD |
| Other Non Cash Items | 2,559USD | 596,113USD | 498USD | 337,249USD | 714,867USD | 1,583USD | 270,307USD | 6,481,497USD |
| Change In Working Capital | 1,845,252USD | -3,693,874USD | 3,699,146USD | 3,164,348USD | -780,021USD | 833,782USD | -425,619USD | 83,777USD |
| Total Cash From Operating Activities | -13,811,107USD | -17,113,299USD | -14,140,031USD | -10,557,815USD | -13,538,309USD | -7,318,018USD | -3,553,472USD | -716,385USD |
| Capital Expenditures | -18,175USD | -4,188USD | -3,901USD | -4,422USD | -5,748USD | -17,945USD | -20,120USD | -5USD |
| Free Cash Flow | -13,829,282USD | -17,117,487USD | -14,143,932USD | -10,562,237USD | -13,544,057USD | -7,335,963USD | -3,573,592USD | -716,385USD |
| Total Cashflows From Investing Activities | -18,175USD | -4,188USD | -3,901USD | -4,422USD | -5,748USD | -17,945USD | -20,120USD | -20,120USD |
| Net Borrowings | -297,553USD | -300,806USD | -438,733USD | -427,700USD | -477,490USD | -88,081USD | -35,000USD | 886,675USD |
| Total Cash From Financing Activities | 14,568,918USD | 23,030,144USD | 4,637,246USD | 15,613,127USD | 4,509,081USD | 14,134,168USD | 10,259,747USD | 1,160,975USD |
| Sale Purchase Of Stock | -2,043USD | 0USD | — | — | — | 14,222,249USD | 10,294,750USD | 390,500USD |
| Issuance Of Capital Stock | 14,046,430USD | 23,376,375USD | 7,514,265USD | 16,038,093USD | 4,653,821USD | 14,222,249USD | 10,294,747USD | 390,500USD |
| Change In Cash | 739,636USD | 5,912,657USD | -9,506,686USD | 5,050,890USD | -9,034,976USD | 6,798,205USD | 6,686,155USD | 444,590USD |
| Begin Period Cash Flow | 6,461,378USD | 548,721USD | 10,055,407USD | 5,004,517USD | 14,039,493USD | 7,241,288USD | 555,133USD | 110,543USD |
| End Period Cash Flow | 7,201,014USD | 6,461,378USD | 548,721USD | 10,055,407USD | 5,004,517USD | 14,039,493USD | 7,241,288USD | 555,133USD |
| Other Cashflows From Financing Activities | 818,457USD | -45,425USD | 2,758,380USD | 2,734USD | 332,750USD | -45,000USD | 10,259USD | 470,475USD |
| Unclassified Financing Cash Flow | 14,050,057USD | 23,376,375USD | -5,196,666USD | — | — | — | — | — |
| Investments | — | -4,188USD | -1,743USD | -4,422USD | -5,748USD | -17,945USD | -20,120USD | — |
| Change To Liabilities | — | — | — | — | 576,493USD | 1,155,135USD | 153,609USD | 71,368USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 6,798,205USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.